Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Menorrhagia 1Leiomyoma 1

Interventions

relugolix 5Uterine Myomectomy 5Bupivacaine 4epigallocatechin gallate 2Vitamin D 2Vitamin B 6 2Sodium Chloride 2Observation 2Norethindrone Acetate 2Estradiol 2vilaprisan 1linzagolix 1elagolix 1Videotape Recording 1Uterine Artery Embolization 1Triamcinolone Acetonide 1Triamcinolone 1Therapeutics 1Tea 1Surveys and Questionnaires 1Standard of Care 1Simvastatin 1Saline Solution 1Robotic Surgical Procedures 1Restraint, Physical 1Radiofrequency Ablation 1Naproxen 1Morphine 1Methadone 1Megestrol Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leiomyoma × elagolix × 1 year × Clear all
NCT03271489 2025-07-22

Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women

AbbVie

Phase 3 Completed
478 enrolled 9 charts

Leiomyoma, Menorrhagia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡